MAS-Seq Supports Isoform Research Using Single-Cell RNA Sequencing from 10x Genomics This press releases is also available in Chinese , Japanese and Korean. MENLO PARK, Calif., Oct. 20, 2022 /PRNewswire/…
Alliance panels include a 50-gene pharmacogenomics panel and a nearly 400-gene panel of challenging, medically relevant “dark genes” developed in collaboration with leading institutions This press release is also…
The Consortium Will Build a Publicly Available Database as a Resource to Accelerate Insights from Long-Read Human Genome Datasets This release is available in Chinese MENLO PARK, Calif., Oct. 18,…
Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif., Sept. 27, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,…
MENLO PARK, Calif., Sept. 7, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the upcoming…
MENLO PARK, Calif., Aug. 19, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that the Compensation Committee of the Company’s Board…
MENLO PARK, Calif., Aug. 5, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana…
MENLO PARK, Calif., Aug. 3, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022. Second quarter results Revenue of $35.5 million, a…
MENLO PARK, Calif., July 21, 2022 /PRNewswire/ – PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial…
MENLO PARK, Calif., July 18, 2022 – PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday,…
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…
Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi Long-Read Sequencing MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB),…
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) — PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s…
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million,…
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration with Children’s Mercy Kansas…
Clear filters
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.